Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections.

"Declarations Conflict of InterestThe authors declare no competing interests. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of Interest The authors declare no competing interests."

"Funding Open access funding provided by University of Cape Town. This work was supported by grants from the Bill and Melinda Gates Foundation (grant number INV-027876) and the US National Institute of Child Health and Human Development (grant number R01HD089831-05). Anna-Ursula Happel is supported by a European and Developing Countries Clinical Trials Partnership (EDCTP) Career Development Fellowship (CDF), which is part of the EDCTP2 programme supported by the European Union (grant number TMA2020CDF-3192-VaViBa). Christina Balle was supported by bursary funds from the Poliomyelitis Research Foundation (fund number 17/43) during her Ph.D. work. Renee Heffron received funding from the National Institutes of Health (grant number K24MH123371)."